A critical discovery in cancer research is emerging with the use of mini-antibodies to restore dysfunctional p53. This essential malignant inhibitor protein is frequently inactivated in several types of tumors, leading https://onelifesocial.com/story7421094/vhh-fragments-restore-the-p53-protein-a-promising-pathway-for-cancer-treatment